FR6631M - - Google Patents
Info
- Publication number
- FR6631M FR6631M FR990822A FR990822A FR6631M FR 6631 M FR6631 M FR 6631M FR 990822 A FR990822 A FR 990822A FR 990822 A FR990822 A FR 990822A FR 6631 M FR6631 M FR 6631M
- Authority
- FR
- France
- Prior art keywords
- ethyleneimino
- spores
- injection
- administered
- tumour
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000000259 anti-tumor effect Effects 0.000 abstract 3
- -1 ethyleneimino Chemical group 0.000 abstract 3
- 238000002347 injection Methods 0.000 abstract 3
- 239000007924 injection Substances 0.000 abstract 3
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 abstract 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 2
- 229940100198 alkylating agent Drugs 0.000 abstract 2
- 239000002168 alkylating agent Substances 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 229940005561 1,4-benzoquinone Drugs 0.000 abstract 1
- 241000193403 Clostridium Species 0.000 abstract 1
- 241000282414 Homo sapiens Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 229940127089 cytotoxic agent Drugs 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- ODKNJVUHOIMIIZ-RRKCRQDMSA-N floxuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(F)=C1 ODKNJVUHOIMIIZ-RRKCRQDMSA-N 0.000 abstract 1
- 229960000961 floxuridine Drugs 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 229960004857 mitomycin Drugs 0.000 abstract 1
- 230000000174 oncolytic effect Effects 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N3/00—Spore forming or isolating processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR990822A FR6631M (enrdf_load_stackoverflow) | 1963-07-10 | 1964-10-08 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29418563A | 1963-07-10 | 1963-07-10 | |
| FR981323 | 1964-07-09 | ||
| FR990822A FR6631M (enrdf_load_stackoverflow) | 1963-07-10 | 1964-10-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR6631M true FR6631M (enrdf_load_stackoverflow) | 1969-01-20 |
Family
ID=23132267
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR990822A Expired FR6631M (enrdf_load_stackoverflow) | 1963-07-10 | 1964-10-08 |
Country Status (3)
| Country | Link |
|---|---|
| BE (1) | BE650279A (enrdf_load_stackoverflow) |
| FR (1) | FR6631M (enrdf_load_stackoverflow) |
| GB (1) | GB1069144A (enrdf_load_stackoverflow) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7470426B1 (en) | 1997-10-09 | 2008-12-30 | Wellstat Biologics Corporation | Treatment of neoplasms with viruses |
| US20030044384A1 (en) | 1997-10-09 | 2003-03-06 | Pro-Virus, Inc. | Treatment of neoplasms with viruses |
| US7780962B2 (en) | 1997-10-09 | 2010-08-24 | Wellstat Biologics Corporation | Treatment of neoplasms with RNA viruses |
| AU4246900A (en) | 1999-04-15 | 2000-11-02 | Pro-Virus, Inc. | Treatment of neoplasms with viruses |
| US8147822B1 (en) | 1999-09-17 | 2012-04-03 | Wellstat Biologics Corporation | Oncolytic virus |
| ATE319460T1 (de) | 1999-09-17 | 2006-03-15 | Wellstat Biologics Corp | Onkolytisches vesicular stomatitis virus |
| CN108102945B (zh) * | 2012-04-27 | 2021-08-24 | 山东新创生物科技有限公司 | 包含戈氏梭菌的衍生细菌菌株的组合物及其使用方法 |
-
1964
- 1964-07-01 GB GB27185/64A patent/GB1069144A/en not_active Expired
- 1964-07-08 BE BE650279D patent/BE650279A/xx unknown
- 1964-10-08 FR FR990822A patent/FR6631M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| BE650279A (enrdf_load_stackoverflow) | 1965-01-08 |
| GB1069144A (en) | 1967-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1424456A (en) | Magnetic medical treatment device | |
| GB1382056A (en) | Moulding apparatus | |
| FR6631M (enrdf_load_stackoverflow) | ||
| GB1025082A (en) | Fabric cleaning and drying machines | |
| GB1440478A (en) | 4-thiopyrimido-4,5-d-pyrimidines | |
| GB990271A (en) | Improvements in or relating to trolleys of personally propelled type | |
| ES365035A1 (es) | Procedimiento para la produccion de n1-(4-amino-2-hidroxi- butiril)-4-o-(2,6-diamino-2,6-clideoxi-d-glicopiranosil)-5- o-d-xilofuranosil-2-desoxiestreptamina,n1-(4-amino-2-hidro- xibutiril)-4-o-(2,6-diamino-2,6-dideoxi-d-glucopirano. | |
| FR2219159A1 (en) | Adamantane nitroxide radicals - antiviral and anticancer agents, also useful in nuclear resonance magnetometry | |
| GB1205966A (en) | 4'-DEMETHYL-EPIPODOPHYLLOTOXIN-beta-D-ETHYLIDENE-GLUCOSIDE | |
| GB1340674A (en) | Urethanes toys or amusement devices suitable for use as stilts | |
| GB941203A (en) | Improvements in endless belt conveyors | |
| ES392531A1 (es) | Procedimiento para la halogenacion de olefinas. | |
| GB758819A (en) | Improvements in fencing posts | |
| GB604729A (en) | An improved clothes horse | |
| FR2410476A1 (fr) | Application des peptidoglycanes extraits de bacteries, en particulier des bacillus a titre de medicaments, notamment stimulant l'immunite antitumorale | |
| USD163033S (en) | Bottle carrier | |
| ES425444A1 (es) | Procedimiento para tenir en la masa compuestos organicos depeso molecular alto. | |
| GB970365A (en) | Preparations for the treatment of tumours | |
| GB622519A (en) | Improvements in or relating to gate and door supports | |
| USD231689S (en) | Drawbolt | |
| GB995699A (en) | Bacterial lysate or fraction thereof | |
| ES257181A1 (es) | Procedimiento para la obtenciën de un nuevo antibiëtico | |
| GB999707A (en) | Improvements in or relating to tedders | |
| FR2047870A1 (en) | Tetracyclins derivs for use as antibiotics | |
| AU260396B2 (en) | Improvements in the processing of high cis-1,4 butadiene-1,3 polymers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |